SharesGrow 7-Criteria Score
All 7 criteria scored · valuation-related highlighted on this page
Awakn Life Sciences Corp. (AWKNF) .
Criteria proven by this page:
- VALUE (0/100, Fail) — the composite valuation score falls below the 60/100 threshold required to pass.
Overall SharesGrow Score: 22/100 with 0/7 criteria passed.
SharesGrow 7-Criteria Score
✗
HEALTH
0/100
Debt-to-Equity & liquidity
→ Health
Valuation Snapshot — AWKNF
Valuation Multiples
P/E (TTM)0.0
Forward P/EN/A
PEG RatioN/A
Forward PEGN/A
P/B Ratio0.00
P/S Ratio21.62
EV/EBITDA0.0
Per Share Data
EPS (TTM)$-0.18
Book Value / Share$0.00
Revenue / Share$0.00
FCF / Share$0.00
Yields & Fair Value
Earnings YieldN/A
Dividend Yield0.00%
P/E Ratio & Earnings Yield
Earnings Per Share (EPS) History
| Year |
EPS (Diluted) |
Revenue |
Net Income |
Net Margin |
| 2021 |
$-0.10 |
$0.00 |
$-1.26M |
- |
| 2022 |
$-0.73 |
$236.04K |
$-15.95M |
-6755.7% |
| 2023 |
$-0.36 |
$1.5M |
$-9.14M |
-611.4% |
| 2024 |
$-0.18 |
$87.37K |
$-5.1M |
-5840.1% |
